Efmoroctocog alfa
Definition: Efmoroctocog alfa, sold under the brand name Elocta among others, is a medication for the treatment and prophylaxis of bleeding in people with hemophilia A. Efmoroctocog alfa is a recombinant human coagulation factor VIII, Fc fusion protein (rFVIIIFc). It is produced by recombinant DNA technology in a human embryonic kidney (HEK) cell line. source: Wikipedia
- ID
- 718943005
- ID date
- 6 Oct 2017
- Previous ID
- 30995111000001108
- Name
- Efmoroctocog alfa